Wang Aoqi, Liu Jiajia, Wen Jianguo, Luo Yangyang, Fan Zhiwei, Yang Liren, Hu Xi, Luo Ruihan, Yu Yankai, Li Sophia, Zhao Weiling, Zhou Xiaobo
ArXiv. 2025 Aug 27:arXiv:2508.19800v1.
We envision the Full-Body AI Agent as a comprehensive AI system designed to simulate, analyze, and optimize the dynamic processes of the human body across multiple biological levels. By integrating computational models, machine learning tools, and experimental platforms, this system aims to replicate and predict both physiological and pathological processes, ranging from molecules and cells to tissues, organs, and entire body systems. Central to the Full-Body AI Agent is its emphasis on integration and coordination across these biological levels, enabling analysis of how molecular changes influence cellular behaviors, tissue responses, organ function, and systemic outcomes. With a focus on biological functionality, the system is designed to advance the understanding of disease mechanisms, support the development of therapeutic interventions, and enhance personalized medicine. We propose two specialized implementations to demonstrate the utility of this framework: (1) the metastasis AI Agent, a multi-scale metastasis scoring system that characterizes tumor progression across the initiation, dissemination, and colonization phases by integrating molecular, cellular, and systemic signals; and (2) the drug AI Agent, a system-level drug development paradigm in which a drug AI-Agent dynamically guides preclinical evaluations, including organoids and chip-based models, by providing full-body physiological constraints. This approach enables the predictive modeling of long-term efficacy and toxicity beyond what localized models alone can achieve. These two agents illustrate the potential of Full-Body AI Agent to address complex biomedical challenges through multi-level integration and cross-scale reasoning.
我们设想全身人工智能代理是一个综合性人工智能系统,旨在跨多个生物层次模拟、分析和优化人体的动态过程。通过整合计算模型、机器学习工具和实验平台,该系统旨在复制和预测从分子、细胞到组织、器官及整个身体系统的生理和病理过程。全身人工智能代理的核心在于强调这些生物层次之间的整合与协调,从而能够分析分子变化如何影响细胞行为、组织反应、器官功能和全身结果。该系统以生物功能为重点,旨在增进对疾病机制的理解,支持治疗干预措施的开发,并加强个性化医疗。我们提出两种专门的实现方式来展示此框架的效用:(1)转移人工智能代理,这是一种多尺度转移评分系统,通过整合分子、细胞和全身信号来表征肿瘤在起始、播散和定植阶段的进展;(2)药物人工智能代理,这是一种系统级药物开发范式,其中药物人工智能代理通过提供全身生理约束来动态指导临床前评估,包括类器官和基于芯片的模型。这种方法能够实现超越局部模型单独所能达到的长期疗效和毒性的预测建模。这两种代理说明了全身人工智能代理通过多层次整合和跨尺度推理应对复杂生物医学挑战的潜力。